Purpose Dual Treatment SPF 10
NDC 87033-2000, Octinoxate 7.5%, Octisalate 5%, Oxybenzone 3%, lotion, from Elysium Consumer Healthcare LLC.
- Product NDC
- 87033-2000
- Status
- Listed
- Labeler
- Elysium Consumer Healthcare LLC
- Dosage form
- LOTION
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M020
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/87033-2000 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OXYBENZONE3 g/100g
- OCTINOXATE7.5 g/100g
- OCTISALATE5 g/100g
| Package NDC | NDC-11 | Package |
|---|---|---|
| 87033-2000-1 | 87033200001 | 1 BOTTLE, PLASTIC in 1 CARTON (87033-2000-1) / 113 g in 1 BOTTLE, PLASTIC |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 87033-2000 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/87033-2000 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 87033-2000. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.